The round was co-led by healthcare investment specialists Gilde Healthcare, and long-time partners and investors of Withings, Idinvest Partners and Bpifrance through their large venture capital funds as well as the support of BNP Paribas Developpement , Oddo BHF Private Equity and Adelie Capital.
Founded in 2008, Withings has a vast ecosystem of connected non-invasive health devices. Its portfolio includes smart scales, blood pressure monitors, smart watches, sleep monitors and thermometers. Its medical-grade devices capture 20 vital health parameters such as blood pressure, ECG, weight, heart rate, activity levels, as well as sleep apnea and sleep patterns.
“I strongly believe in the ability of technology to transform the health of society by enabling anyone to regularly monitor their vital signs at home and involve healthcare professionals in this process. Today we are in an exciting period where medicine is becoming personalized, continuous and based on data analysis, and I am proud that Withings is at the heart of this revolution, said President and Co-Founder Eric Carreel.
“With funding from like-minded partners, we can expand our efforts globally and continue to invest in new technologies and AI tools capable of detecting and predicting medical conditions,” he said. he adds.
Last year, Withings launched MED PRO, a dedicated business-to-business division that enables healthcare professionals, institutions, payers, disease management programs, coaching platforms and researchers to operate the devices. Withings and data analysis within their own ecosystems. It offers telemedicine and remote patient services and solutions for dedicated health programs that manage chronic diseases such as diabetes, hypertension, heart health, sleep, and weight management.